Cycling cells duplicate their DNA content during S phase, following a defined program called replication timing (RT). Early and late replicating regions differ in terms of mutation rates, transcriptional activity, chromatin marks and sub-nuclear position. Moreover, RT is regulated during development and is altered in disease . Exploring mechanisms linking RT to other cellular processes in normal and diseased cells will be facilitated by rapid and robust methods with which to measure RT genome wide. Here, we describe a protocol to analyse genome-wide RT by next-generation sequencing (NGS). This protocol yields highly reproducible results across laboratories and platforms. We also provide the computational pipelines for analysis, parsing phased genomes using single nucleotide polymorphisms (SNP) for analyzing imprinted RT, and for direct comparison to Repli-chip data obtained by analyzing nascent DNA by microarrays.
INTRODUCTION
DNA replication occurs during S phase of the cell cycle. In human cells, this process lasts around 8 hours (Weber et al., 2014) . Different regions of the genome replicate at different times during S phase, following a defined replication timing (RT) program (Hiratani et Dixon et al.,2015) , while domains of coordinately regulated RT (replication domains; RDs) align with topologically associating domains (TADs) (Pope et al., 2014) . Accurate methods to analyse RT are essential to explore the links between all these processes.
Genome-wide RT analysis methods are based on the quantification of replicated genomic regions at different times during S phase. Multiple techniques have been developed to assess RT. One of the major applications, repli-chip uses BrdU pulse labeling of nascent DNA, Fluorescence Activated Cell Sorting (FACS) to separate cells into different times during S phase (Gilbert, 1986; Gilbert and Cohen, 1987) , and BrdU immunoprecipitation to isolate newly synthesized DNA at different time points of the S phase (Hiratani, 2008; Ryba et al., 2011) . This newly synthesized DNA is then quantified by microarray hybridization. Subsequently, Hansen et. al. sequenced the newly synthesized DNA produced from BrdU labeling and FACS sorting to coin the term Repli-seq (Hansen et al., 2010) . The number of S phase fractions can be varied in this protocol, from 2 fractions (early vs. late) to produce a simple ratio of enrichment in early vs. late S phase, to multiple fractions (to date up to 8) of S phase (Gilbert, 1986; Gilbert and Cohen, 1987; Hansen et al., 1993; Hansen et al., 2010 ) Both 2 and 6 fraction Repli-chip vs. Repli-seq give highly similar profiles after smoothing and normalization (Pope et al., 2014) . Taking multiple fractions of S phase to date has provided little in the way of increased resolution, due to the fact that the labeling times with BrdU necessary for effective BrdU-IP (>60 minutes) label several hundreds of kilobases of DNA. Multiple fractions can, however, give information on synchrony of replication between homologous chromosomes or across a population; highly asynchronous replication would give BrdU incorporation across S phase with multiple fractions but would average out to be indistinguishable from middle replication in a 2 fraction ratio method. When large numbers of different cell types or experimental conditions are being compared, however, the 2-fraction protocol is considerably faster and more robust in both wet and computational processing, provides highly reliable data with well established quality control standards and can be easily integrated in next generation sequencing analysis pipelines. We previously published a genome-wide RT analysis protocol based on microarray hybridization: repli-chip ). Here we summarize our newly adapted repli-seq protocol. While microarray processing can be less expensive both in wet and computational costs, sequencing of newly synthesized DNA in repli-seq provides distinct advantages. Sequencing allows one to overcome species limitations with microarray availability, and provides superior sensitivity to allele-specific microarrays in cases of studies needing sequence specificity such as distinguishing single nucleotide polymorphism (SNPs) / quantitative trait loci (Koren et al., 2014; Mukhopadhyay et al., 2014; Bartholdy et al., 2015) or to compare homologous chromosomes with phased genomes.
We describe here the complete optimized repli-seq experimental procedures and bioinformatic analysis pipeline developed and routinely used in the lab for rapid high confidence analysis of samples containing as few as two thousand S phase cells. This protocol generates data to study RT at the genome-wide level, in a sequence specific manner. We have successfully applied this protocol to human and mouse embryonic stem cells (ESC), ESC-derived, primary cells, and cell lines, as well as frozen viable banked tissue samples (Pope et al., 2014; Wilson et al., 2016 ; unpublished work). Moreover, this protocol could be easily adaptable to study other species and allow to measure allele-specific RT if the phased genome is available.
Overview
The experimental parts of this protocol starts from cultured cells, and ends by the sequencing of the samples. This experimental part is composed of 9 steps. The analysis part of the protocol starts from the fastq or fastq.gz files obtained after sequencing and generates normalized bedgraph files that can be used for further bioinformatics studies. An overview of the total protocol is presented in Figure 1 . Labeling and fixation. This step is performed on cells that can be pulse-labelled.
Asynchronously proliferating cells are pulse-labeled with BrdU to mark newly synthesized DNA. Depending on where in S phase each cell is, early or late replicating regions on the genome are BrdU-labeled cells are then fixed with ethanol, to prevent further BrdU incorporation into the genome. The resolution of the repli-seq is to a certain extent limited by the labelling time. FACS sorting. BrdU-labeled cells are stained with propidium iodide (PI) to assess the cell cycle phase of each cell, through their DNA content. Cells are sorted by FACS according to their DNA content based on the PI staining, to isolate two cell populations: early S cells and late S cells. DNA preparation and fragmentation. Genomic DNA from early and late S phase is purified and fragmented. DNA fragmentation is performed by sonication on a Covaris. The advantages of Covaris are 1) it fragments DNA into a relatively tight size distribution reproducibly, hence there is no need for subsequent size selection most of the time, 2) the same conditions work for a broad range of DNA concentrations (50-5000ng). Although Covaris consumables are expensive, these advantages make the total cost of library construction lower than fragmenting DNA using other methods. The fragmentation is performed to obtained DNA fragments of an average length of 200bp if sequencing is performed as 50 to 100 bp single end mode. Reads length and fragments size can be adapted for specific purpose. For example, for hybrid cells, we started with 250bp reads length on more than 500bp fragments. Fragment size distribution is crucial for the final sequencing. Library construction. This step begins prior to the BrdU labeled DNA immunoprecipitation (BrdU IP). There are many advantages to construct the libraries before the BrdU IP. First, amount of available DNA is higher than after the IP. Constructing libraries from small amount of DNA is more challenging. Moreover, BrdU IP generates single-strand DNA, which means that constructing the libraries after the BrdU IP would need to convert it to double-strand DNA, which would add one more step to the protocol, and could lead to the introduction of artifacts, bias. The kit used to construct the library depends on the sequencer you will use. We use a NEB kit for Illumina sequencer. Libraries are constructed according to the manufacturer protocol, and follow three steps: ends repair and dA tailing, adaptors ligation, USER treatment. BrdU Immunoprecipitation. DNA fragments, linked to the adaptors, are immunoprecipitated with an anti-BrdU antibody and a mouse secondary antibody. Indexing and PCR amplification. DNA is indexed during the PCR amplification step, using NEB kit. The optimum number of PCR cycles should be determined by qPCR if necessary. . Post-PCR Purification. DNA is purified to remove PCR reagents, primers and primer dimers, and proteins contamination. We use AMPure XP beads. Quality Control, Pooling and Sequencing. Quality control is an important step to avoid sequencing low quality samples which could not be used for further analysis. This step includes the quantification of DNA concentration for each sample and the analysis of the size distribution of the library. The performance of the BrdU-IP is assessed by quantitative PCR in known early and late replicating regions, if these data are available for your samples. After these quality control steps, libraries are pooled for sequencing. The pool of libraries is checked regarding size distribution and molar concentration before they are sequenced. Sequencing is performed on HiSeq illumina sequencer. Analysis. Analysis is performed on the reads files generated by the sequencing. Reads are mapped onto the genome using bowtie2. The coverage is assessed for each samples, and the base 2 log ratio of early onto late S phase samples is calculated in genomic windows. All these steps can be performed using R software or in command line. Next, base 2 log ratio files are post-processed using R. Post-processing allows the comparison between samples when comparing samples with local RT changes. Post-processing includes quantile normalization and optionally Loess smoothing. We do not recommend to use the quantile normalization when comparing datasets with global RT changes. Loess smoothing can be skipped if you use overlapping genomic windows for coverage assessment. The analysis generates, for each sample, one bedgraph coverage file of post-processed log2 ratio of early onto late S phase cells sample. These files can be viewed using a genome viewer ( REAGENTS SETUP -Cells of interest Cultures can be grown in any size cell culture dish, but must be in an actively dividing state for use in this protocol. If you have to start from non-proliferating / metabolically inactive cells, use S/G1 method described in Ryba et al., 2011. FACS can be problematic with a low cell number, we recommend to use 2 x 10 6 cells. We have once successfully profiled RT using as low as 300,000 cells as the starting material, but this does not happen with every sample. Cells are lost during PI staining, filtering, sorting. CAUTION All experiments should be performed in accordance with relevant guidelines and regulations.
-BrdU (5-bromo-2'-deoxyuridine) (Sigma Aldrich, B5002) Make stock solutions of 10 mg/mL (and 1 mg/mL if you need to handle a small scale of culture) in ddH 2 O and store at -20°C in aliquots, protected from light. -Propidium Iodide (1 mg/mL) (PI) To make 20 mL, dissolve 20 mg Propidium Iodide powder in autoclave ddH 2 O to achieve a final volume of 20 mL and filter. Store for up to one year at 4°C protected from light. -PBS / 1% FBS / PI / RNase A Add 50 µl of 1 mg/ml PI, 25 μl of 10 mg/ml Rnase A to every 1 ml of PBS-1% FBS -SDS-PK buffer To make 50 mL, combine 34 mL autoclaved ddH 2 O, 2.5 mL 1M Tris-HCl pH 8.0, 1 mL 0.5 M EDTA, 10 mL 5 M NaCl and 2,5 mL 10% (wt/vol) SDS (Invitrogen 15525017) in H 2 O. Store at room temperature. Warm to 56°C before use to completely dissolve SDS. -10X IP buffer To make 50 mL, combine 28.5 mL ddH 2 O, 5 mL 1M Sodium Phosphate pH 7.0, 14 mL 5 M NaCl, and 2.5 mL 10% (wt/vol) Triton X-100 in H 2 O . Store at room temperature.
-anti-BrdU antibody 12.5 μg/ml Dilute antibody in 1X PBS from the stock concentration of 0.5 mg/mL to a final concentration of 12.5 μg/mL. Prepare 40 μl of diluted antibody for each sample and discard unused diluted antibody. -Digestion buffer To make 50 mL, combine 44 mL autoclaved ddH 2 O, 2.5 mL 1M Tris-HCl pH 8.0, 1 mL 0.5 M EDTA, and 2.5 mL 10% (wt/vol) SDS in H 2 O. Store at room temperature. CRITICAL STEP Double check the cell number at this point, after adding ethanol, it will be harder to count the cells since FBS makes precipitation. 9. Add 7.5 mL of ice-cold 100% EtOH, dropwise while gently vortexing (use the lowest rpm or hand shake the tube to avoid cell lysis by vigorous vortexing) 10. Seal cap, mix tube gently but thoroughly by inverting several times. 11. Store at -20°C until use (and in the dark since BrdU is light-sensitive). Lower temperature may cause freezing which damages cells. PAUSE POINT Fixed cells are stable in -20˚C for more than a year if protected from light and evaporation. Note: Starting from rapidly growing cells helps as they have a large population of S phase cells. In our experience, 2 million total cells give enough early and late S phase cells for one replication assay (60,000 each) most of the time (with >5% cells in S phase). Using round bottom tubes for cell fixation prevents cells from forming packed pellet that is hard to re-suspend later, but if small cell number is an issue, using conical tubes is fine.
Step 2: FACS sample preparation and sorting 1. PAUSE POINT Alternatively, add 1/9 vol. DMSO and freeze in -80°C (light protected) until sorting. On sorting, thaw the cell suspension in a 37°C water bath. Removing DMSO is not necessary. Once thawed, keep the samples on ice in the dark. 22. Request FACS operator to collect 120,000 cells each of early and late S phase cells.
(120,000 cells allow 6 reactions of BrdU IP). CRITICAL STEP It is hard to define the junction between G1 and S. Therefore, include some late G1 into early S fraction In addition, cells in late S phase proceed to G2 during 2hr BrdU labeling, hence include early G2 into late S fraction. Be sure to leave as small a gap as possible between the early and late S sorting windows. Otherwise, data for mid S replicating DNA will be inaccurate. TROUBLESHOOTING
Step 3: DNA preparation from FACS sorted cells 0.5h 23. Centrifuge the sorted cells at 400 x g or sorted nuclei at 800 x g for 10 minutes at 4°C. 24. Decant supernatant gently, only once (If the cell number is small, there may be no supernatant coming out by decanting, but do it for every sample for the consistency). 25. Add 1 mL of SDS-PK buffer containing 0.2 mg/mL Proteinase K every 100,000 cells collected and mix vigorously by tapping the tube. Seal around the tube cap with parafilm so that the caps would not pop out during the next step. If no smear is detected, you need to re-amplify the reaction (the procedure for re-amplification is described in Step 78).
Step 8: Purification 1h 67. Place AMPure XP beads at room temperature for at least 30 minutes. Step 9: Quality control and pooling 5h 77. Check the DNA concentration using 1 µL of the library on Qubit dsDNA HS Assay Kit.
(See Qubit manual). Expect 10-20 ng/µl. If the concentration is below detection, do another Qubit assay using 10 µL. This helps to determine the number of PCR cycles necessary for re-amplification. If the DNA concentration is higher than 7 ng/µL, skip the
Step 76. 78. If the DNA concentration is less than 7 ng/µl, you will likely have problems making the final 10 nM pool, so you will need to re-amplify the sample. Please note that it is better to use more PCR cycles from the beginning rather than re-amplifying, because re-amplification includes one more step of purification. Re-amplification can be done as following: (i) Mix the components of the (Figure 2 ), allowing high confidence identification of differences between samples.
Accuracy Repli-chip is a well accepted method to study RT. We have shown that repli-seq gives similar results to repli-chip, in both human and mouse cells (Pope et al., 2014 ; Figure 3) , and that comparisons of genome-wide RT can be made between repli-seq and repli-chip. The two platforms can even be combined for clustering experiments. The advantages of repli-seq are the genomic coverage (which includes repetitive sequences should those be desirable to analyze), which is dependent only upon the mappability and sequencing depth, the ability to distinguish SNPs or parse phased genomes, and the ability to analyze any species with the same method.
Sequence specificity The sequence information obtained from repli-seq can be used to discriminate between homologous regions, if the sequencing breadth is appropriate for the polymorphisms density, permitting the study of differences in RT between homologous regions (Mukhopadhyay et al., 2014) . We show here an example on hybrid mouse embryonic stem cells (Figure 4 ). Discrimination in these cells of the original strain of homologous regions reveals subtle differences between homologous regions. Such regions could be compared with transcription data to study the link between transcription and RT. Repli-seq could also be used to discriminate between the RT of two X chromosomes in hybrid female cells, and the impact of X chromosome activation status on RT. 
